Kinfo
Akerna Corp logo

Akerna Corp

KERNNASDAQHealthcare·US · USD
$8.51
+0.33 (+4.03%)
Prices as of October 2, 2026 · market closed

Price

Key statistics

Valuation
Market cap4.51M USD
Enterprise value18.24M USD
Trailing P/E0.09
Forward P/E-0.09
PEG ratio0.00
Price / sales0.33
Price / book-7.58
Profitability
Gross margin53.20%
Operating margin-428.64%
Profit margin60.33%
Return on assets-410.99%
Return on equity1658.12%
Income (TTM)
Revenue13.65M USD
Gross profit8.23M USD
EBITDA0.00 USD
Net income-80.01M USD
Diluted EPS-$27.33
Rev. growth (YoY)-8.97%
Balance sheet
Total cash209.58K USD
Total debt8.58M USD
Debt / equity-0.93
Current ratio0.10
Book value / share-$1.12
Cash flow (TTM)
Operating cash flow-73.13M USD
Levered free cash flow4.56M USD
Shares & price
Shares outstanding517.60K
Float0.00
Held by institutions0.00%
Beta0.00
50-day MA$0.00
200-day MA$0.00
52-week high$11.05
52-week low$0.67
Earnings (EPS)
DateEst.ActualSurprise2026-03-040.060.15+150.00%2023-11-13-0.43-0.32+25.58%2023-08-13-0.32-0.52−62.50%
About Akerna Corp

Akerna Corp. provides enterprise software solutions that enable regulatory compliance and inventory management in the United States and Canada. The company offers MJ Platform for the cannabis, hemp, and CBD industry; and Leaf Data Systems, a government regulatory software. It also provides consulting services to cannabis industry; business intelligence, data analytics and other software related services; and Last Call Analytics, a retail analytics platform. In addition, the company operates Solo, a seed-to-sale tagging and tracking software platform, and Trellis, a cultivation and compliance software platform. Akerna Corp. was founded in 2010 and is headquartered in Denver, Colorado.

Sector
Healthcare
Industry
Health Information Services
CEO
Ms. Jessica Billingsley
Employees
112
Headquarters
Denver, CO, United States

Frequently asked questions about Akerna Corp